Bowman-Birk Inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease
View Patent ↗Methods for use of a composition comprising Bowman-Birk Inhibitor (BBI) or a derivative thereof in the treatment and/or prevention of skeletal muscle atrophy, to improve of skeletal muscle function, and to alleviate symptoms and/or slow progression of degenerative skeletal muscle diseases or disorders are provided.
1. A method for slowing progression of skeletal muscle atrophy in a subject comprising administering to the subject a composition comprising a therapeutically effective amount of Bowman-Birk Inhibitor.
2. The method of claim 1 wherein the composition is administered orally.
3. The method of claim 2 wherein the composition is administered as a dietary supplement.
4. The method of claim 1 wherein the Bowman-Birk Inhibitor is in a concentrated form.
5. A method for improving skeletal muscle function in a subject in need thereof comprising administering to the subject a composition comprising a therapeutically effective amount of Bowman-Birk Inhibitor wherein improved skeletal muscle function comprises increased muscle strength or increased muscle mass.
6. The method of claim 5 wherein the composition is administered orally.
7. The method of claim 6 wherein the composition is administered as a dietary supplement.
8. The method of claim 5 wherein the Bowman-Birk Inhibitor is in a concentrated form.
9. A method for treating skeletal muscle degeneration in a subject comprising administering to the subject a composition comprising a therapeutically effective amount of Bowman-Birk Inhibitor.
10. The method of claim 9 wherein the composition is administered orally.
11. The method of claim 10 wherein the Bowman-Birk Inhibitor is in a concentrated form.
12. The method of claim 9 wherein the composition comprises Bowman-Birk Inhibitor Concentrate.
13. A method for slowing progression of a degenerative skeletal muscle disorder or disease in a subject in need thereof comprising administering to the subject a composition comprising a therapeutically effective amount of Bowman-Birk Inhibitor.
14. The method of claim 13 wherein the composition is administered orally.
15. The method of claim 14 wherein the composition is administered as a dietary supplement.
16. The method of claim 13 wherein the Bowman-Birk Inhibitor is in a concentrated form.
17. The method of claim 13 wherein the degenerative skeletal muscle disorder or disease is muscular dystrophy, amyotrophic lateral sclerosis, spinal muscle atrophy or spinal cord injury.